Rheumatology

                   

Study Results Demonstrate More Patients With Early Erosive Rheumatoid Arthritis Treated With ORENC..

euroinvestor.co.uk
27-Oct-2008
        

Bristol-Myers Squibb Company (NYSE: BMY) today announced results from a Phase IIIb study in adult patients with early moderate-to-severe erosive rheumatoid arthritis (RA) who had never received previous methotrexate (MTX)...

add comment
                   

Data Demonstrate ORENCIA(R) (Abatacept) Improves Health-Related Quality of Life, Pain and Sleep...

redorbit.com
28-Oct-2008 1 related
        

Bristol-Myers Squibb Company (NYSE: BMY) today announced at the American College of Rheumatology (ACR) Annual Scientific Meeting in San Francisco results from a 10-month study which showed that ORENCIA(R) (abatacept), compared...

add comment

Etanercept, Methotrexate Safe for Juvenile RA (HealthDay)

yahoo.com
28-Oct-2008
        

MONDAY, Oct. 27 (HealthDay News) -- The drugs etanercept and methotrexate are safe and effective for long-term, continuous treatment of juvenile rheumatoid arthritis, new research finds. In a three-year study that enrolled...

add comment
                   

Data Demonstrate ORENCIA(R) (abatacept) Improves Health-Related Quality of Life, Pain and Sleep...

finanzen.net
28-Oct-2008
        

Bristol-Myers Squibb Company (NYSE: BMY) today announced at the American College of Rheumatology (ACR) Annual Scientific Meeting in San Francisco results from a 10-month study which showed that ORENCIA® (abatacept), compared to...

add comment
                   

Data Demonstrate ORENCIA(R) (abatacept) Improves Health-Related Quality of Life, Pain and Sleep...

finanznachrichten.de
28-Oct-2008
        

Bristol-Myers Squibb Company (NYSE: BMY) today announced at the American College of Rheumatology (ACR) Annual Scientific Meeting in San Francisco results from a 10-month study which showed that ORENCIA® (abatacept), compared to...

add comment
                   

Study Results Demonstrate More Patients With Early Erosive Rheumatoid Arthritis Treated With...

finanzen.net
27-Oct-2008
        

Bristol-Myers Squibb Company (NYSE: BMY) today announced results from a Phase IIIb study in adult patients with early moderate-to-severe erosive rheumatoid arthritis (RA) who had never received previous methotrexate (MTX)...

add comment

Etanercept, Methotrexate Safe for Juvenile RA

medicinenet.com
28-Oct-2008
        

new research finds. In a three-year study that enrolled about 600 patients, aged 2 to 18, some of the children took methotrexate alone, others took etanercept alone, and another group took both drugs. Etanercept was given as...

add comment

New Drug May Strengthen Women's Bones

medicinenet.com
28-Oct-2008
        

MONDAY, Oct. 27 (HealthDay News) -- The drug denosumab can boost bone mass in postmenopausal women, according to a study that followed almost 1,200 women, average age 64, with low bone mass for more than one year. Denosumab...

add comment
                   

Rheumatoid Arthritis a Threat to the Heart

medicinenet.com
28-Oct-2008
        

MONDAY, Oct. 27 (HealthDay News) -- These are the conclusions of three reports presented at the American College of Rheumatology (ACR) annual scientific meeting, which runs from Oct. 24-29, in San Francisco. "Rheumatoid...

add comment
                   

Treatment Guidelines for Psoriatic Arthritis

health.am
28-Oct-2008
        

Rheumatologists, dermatologists, and patient advocates have come together to publish the first-ever international guidelines for the treatment of psoriatic arthritis, a disease that mainly affects people who have psoriasis but...

add comment